David R. Bundle

Patents

1. Lemieux, R.U., Bundle, D.R. and Baker, D.A.  Synthetic polysaccharide antigenic determinant for human blood groups.  American, British, Canadian, Dutch, French and West German patents pending.  U.S. Patent 4,137,401, January 30, 1979.
2. Lemieux, R.U., Bundle, D.R. and Baker, D.A.  Artificial oligosaccharide antigenic determinants.  United States Patent 4,238,473, December 8, 1980.
3. Bundle, D.R., Perry, M., Cherwonogrodzky, J., Duncan, R. and Caroff, M.  Identification of Brucella abortus and Brucellosis infection.  Canadian Patent No. 1,212,051, Sept. 30, 1986.
4. Bundle, D.R., Perry, M.B., Cherwonogrodzky, J.W., Duncan, J.R. and Caroff, M.G. Antigenic polysaccharide specific to Brucella abortus and Yersinia enterocolitica serotype O:9.  United States Patent No. 4,831,126, May 16, 1989.
5. Cherwonogrodzky, J.W., Duncan, R., Nielsen, K., Wright, P., Bundle, D.R. and Perry, M.B.  Immunoassays for Discriminating between Brucellosis Infections and Vaccinations. United States Patent 5,006,463. April 9, 1991.
6. Cherwonogrodzky, J.W., Duncan, R., Nielsen, K., Wright, P., Bundle, D.R. and Perry, M.B.  Immunoassays for Discriminating between Brucellosis Infections and Vaccinations. Canadian Patent 1,336,576, August 8, 1995.
7. Srivastava, O.P., Srivastava, G., Szweda, R., Bundle, D.R., Hindsgaul, O., Hanna, H.R., Holme, K., Barresi, F.W. and Du, M.  Oligosaccharide Glycosides having Mammalian Immunosuppressive and Tolerogenic Properties.  U.S. 5,784,411.  February 23, 1999.
8. Bundle, D.R., Kitov, P.I., Read, R.J., Ling, H., Armstrong, G.D.  Treatment of Bacterial Dysentery.  U.S. 5962423.  October 5th, 1999.
9. Lennox, R.B., Hodges, R.S., Irvin, R.T., Armstrong, G.D., Kitov, P.I, Railton, C.  Biosensor Device and Method.  U.S. 5,955,379, September 21, 1999.
10. Bundle, D.R., Kitov, P, Read, R.J., Ling, H. and Armstrong, G.  Treatment of Bacterial Infections.  US 6,310,043.  October 30th, 2001.
11. Srivastava, O.P., Srivastava, G., Du, M., Hindsgaul, O., Bundle, D.R. and Liav, Avraham.  Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminc acids.  US 6, 303, 764, October 16, 2001.
12. Bundle, D.R., Nitz, M. and Cutler, J.E. Synthetic anti-Candida albicans oligosaccharide based vaccines. US Provisional patent application, filed April 26th, 2002.
13. Bundle, D.R., Ling, C-C. and Zhang, P.  Synthetic methods for the large scale production from glucose of analogs of sphingosine, azidosphingosine, ceramides, lactosyl ceramides and glycosyl phytosphingosine.  US Provisional patent application filed:  May 31st, 2002.
14. Bundle, D.R., Nitz, M. and Cutler, J.E. Synthetic anti-Candida albicans oligosaccharide based vaccines. U.S. 7,722,890 May 25, 2010.
15. Bundle, D.R., Ling, C-C. and Zhang, P.  Synthetic methods for the large scale production from glucose of analogs of sphingosine, azidosphingosine, ceramides, lactosyl ceramides and glycosyl phytosphingosine.  International  patent application filed:  June 1st, 2003 abandoned.
16. Bundle, D.R., Kitov, P. Glycerol Cyclic Pyruvate Derivatives. US Provisional patent application filed: May 12th, 2003
17. Bundle, D.R., Kitov, P., Ng, K. K-S., Ho, J.G.S. Multivalent Inhibitors of Serum Amyloid P Component. US patent: US 7,553,819, June 30, 2009.
18. Bundle, D.R Wu, X.. Synthesis of glycoconjugate vaccines against Candida albicans using the novel linker methodology. US Provisional Patent application filed: March 14th, 2005.
19. Bundle, D.R Wu, X., Rennie, R. Synthetic anti-Candida albicans oligosaccharide based vaccines. US Provisional Patent application filed: April 29th, 2005.
20. Bundle, D.R., Kitov, P.I. Grant G. Methods and compositions for pharmacologically controlled targeted immunotherapy. US Provisional Patent application filed: November 21st, 2005.
21. Bundle, D.R Wu, X., Rennie, R. Lipinski, T. Synthetic anti-Candida albicans oligosaccharide based vaccines. US Patent application filed: March 14th, 2006.
22. Bundle, D.R., Kitov, P.I. Grant, G. Lipinski, T. Dziadek, S. Methods and compositions for pharmacologically controlled targeted immunotherapy. International and US Patent application Serial No. 11/602,493 filed: November 21, 2006.
23. Bundle, D.R., Kitov, P.I. Multivalent Heterobifunctional Polymer Therapeutics and Methods of Their Use. US Provisional Patent application filed: March 23rd, 2007.
24. Bundle, D. R., Kitov, P. I. Multivalent Heterobifunctional Polymer Therapeutics and Methods of Their Use. International patent application, filed March 20th, 2008.
25. Bundle, D. R. Immunogenic Particles. US Provisional Patent application 61/324,549 filed: April 15th, 2010.
26. Bundle, D. R., Guiard, J. Oligosaccharides for diagnosing brucellosis. United States Provisional Patent Application No. 61/812,396, April 16, 2013.
27. McGiven, J., Bundle, D. R., Guiard, J. “Brucella antigen” United Kingdom Patent Application No. 1306882.0

  Back to People

Profile

Publications

Reviews and Book Chapters

Patents